A new gonadotropin treatment for idiopathic moderate oligoasthenospermia

Twenty-three idiopathic oligoasthenospermic patients were subdivided into three classes according to degree of sperm concentration and typical sperm motility percentage. These patients were treated with 75 I.U. of Urofollitropin every other day for three months. The patients with moderate oligoasthenospermia responded more favorably than patients with severe or more severe oligoasthenospermia.